MetMod (Inflammatory Bowel Disease) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this study to identify new signs and symptoms of inflammatory bowel disease (IBD) in children and young adults. We want to improve at predicting the future course of IBD so that we can treat it better and faster. We also hope this study will help us learn how IBD develops so that we can make new treatments for IBD.

¿Cuál es la Condición que se está estudiando?

Inflammatory Bowel Disease (IBD), including Crohn's Disease, Ulcerative Colitis, and Unspecified IBD

¿Quién puede participar en el Estudio?

Children and adults ages 2-21 who:

  • Are referred by their doctor to have a colonoscopy and biopsy
  • Are suspected to have IBD or have been diagnosed with IBD in the past 2 years
  • Were not using any medications or supplements for IBD prior to diagnosis

For more information, contact the study team at alex.hammett@duke.edu.

Grupo etario
Adultos, Niños

¿Qué Implica?

If you choose to join this study, you will have extra biopsies taken from 3 different parts of you intestine. This will be done at the same time that your doctor is taking routine samples during your regular endoscopy procedure that's part of your normal clinical care.

Detalles del Estudio

Título Completo
POPULATION-BASED CHARACTERIZATION OF METABOLIC PATHWAYS TO PREDICT PEDIATRIC INFLAMMATORY BOWEL DISEASE OUTCOMES (MetMod) - DUHS IRB - sIRB
Investigador Principal
Especialista en gastroenterología pediátrica
Número de Protocolo
IRB: PRO00117943
NCT: NA
ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción